Another strategy involved the infusion of TRAIL overexpressing donor T-cells in mice with resulting increased induced apoptosis of alloreactive T-cells with reduced GVHD in a death receptor 5 (DR5) dependent manner, with an unexpected increase of in vitro and in vivo GVT effect. Here, TNFRSF10B is linked to graft versus host disease.